Not currently recruiting at UCSD
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
Summary
- Eligibility
- for males ages 18 years and up (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Acerand Therapeutics (Hong Kong) Limited
- ID
- NCT06801236
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 67 study participants
- Last Updated